CD200 and B-cell chronic lymphocytic leukemia: In the case of patients with CLL, compared to healthy volunteers, the most sensitive parameters turned out to be the percentage of PD-1 on all subpopulations of the tested lymphocytes and CD4+ CD200+, as well as the concentration of all tested molecules in the serum.